Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -56.99% is 19% below its 5-year average of -47.89%, around the middle of its 5-year range (-101.91%–-25.83%).
As of the fiscal period ended Tuesday, June 30, 2026. 19.39% above its 12-month average of -70.70%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -56.99%.
RETURN ON INVESTED CAPITAL (ROIC)
-56.99%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-70.70%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-62.62%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-47.89%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-58.12%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+19.39%
CURRENT VS 3Y AVG
+9.00%
CURRENT VS 5Y AVG
-18.99%
CURRENT VS 10Y AVG
+1.94%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.50%
median of 663 covered companies
CURRENT VS SECTOR MEDIAN
-70.12%
vs the sector median at left
Aclaris Therapeutics, Inc.
Market Cap
$558.65M
Return on Invested Capital (ROIC)
-56.99%
TTM Avg
-70.70%
3Y Avg
-62.62%
5Y Avg
-47.89%
Market Cap
$566.03M
Return on Invested Capital (ROIC)
27.87%
TTM Avg
-1.63%
3Y Avg
-31.88%
5Y Avg
-39.02%
Market Cap
$560.00M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$567.12M
Return on Invested Capital (ROIC)
-25.42%
TTM Avg
25.46%
3Y Avg
-12.61%
5Y Avg
-20.42%
Market Cap
$555.16M
Return on Invested Capital (ROIC)
-43.41%
TTM Avg
-39.91%
3Y Avg
-39.91%
5Y Avg
-39.91%
Market Cap
$556.87M
Return on Invested Capital (ROIC)
-317.86%
TTM Avg
-177.04%
3Y Avg
-169.25%
5Y Avg
-196.25%
Market Cap
$576.52M
Return on Invested Capital (ROIC)
-45.62%
TTM Avg
-46.61%
3Y Avg
-61.97%
5Y Avg
-71.18%
Market Cap
$540.95M
Return on Invested Capital (ROIC)
-0.81%
TTM Avg
-8.59%
3Y Avg
-110.96%
5Y Avg
-102.03%
Market Cap
$538.58M
Return on Invested Capital (ROIC)
-18.20%
TTM Avg
-95.31%
3Y Avg
-87.63%
5Y Avg
-71.60%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | $558.65M | -56.99% | -70.70% | -62.62% | -47.89% |
| CorMedix Inc. (CRMD)vs › | $566.03M | 27.87% | -1.63% | -31.88% | -39.02% |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX)vs › | $567.12M | -25.42% | 25.46% | -12.61% | -20.42% |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $555.16M | -43.41% | -39.91% | -39.91% | -39.91% |
| Nuvectis Pharma, Inc. (NVCT)vs › | $556.87M | -317.86% | -177.04% | -169.25% | -196.25% |
| Aquestive Therapeutics, Inc. (AQST)vs › | $576.52M | -45.62% | -46.61% | -61.97% | -71.18% |
| Delcath Systems, Inc. (DCTH)vs › | $540.95M | -0.81% | -8.59% | -110.96% | -102.03% |
| Immix Biopharma, Inc. (IMMX)vs › | $538.58M | -18.20% | -95.31% | -87.63% | -71.60% |
| OrthoPediatrics Corp. (KIDS)vs › | $588.70M | -4.97% | -6.49% | -6.53% | -6.86% |
ROIC
-57.0%
ROE
-60.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -56.99% |
| 2026-03-31 | -46.81% |
| 2025-12-31 | -57.70% |
| 2025-09-30 | -101.91% |
| 2025-06-30 | -90.06% |
| 2025-03-31 | -79.90% |
| 2024-12-31 | -75.20% |
| 2024-09-30 | -28.23% |
| 2024-06-30 | -46.36% |
| 2024-03-31 | -55.91% |
| 2023-12-31 | -58.49% |
| 2023-09-30 | -64.07% |
| 2023-06-30 | -52.48% |
| 2023-03-31 | -47.70% |
| 2022-12-31 | -38.62% |
| 2022-09-30 | -33.76% |
| 2022-06-30 | -31.74% |
| 2022-03-31 | -38.18% |
| 2021-12-31 | -39.30% |
| 2021-09-30 | -32.72% |
| 2021-06-30 | -25.83% |
| 2021-03-31 | -43.52% |
| 2020-12-31 | -91.06% |
| 2020-09-30 | -92.88% |
| 2020-06-30 | -100.07% |
| 2020-03-31 | -138.72% |
| 2019-12-31 | -168.12% |
| 2019-09-30 | -122.73% |
| 2019-06-30 | -91.47% |
| 2019-03-31 | -65.36% |
| 2018-12-31 | -54.55% |
| 2018-09-30 | -79.16% |
| 2018-06-30 | -58.94% |
| 2018-03-31 | -43.73% |
| 2017-12-31 | -31.39% |
| 2017-09-30 | -23.31% |
| 2017-06-30 | -30.08% |
| 2017-03-31 | -30.12% |
| 2016-12-31 | -28.59% |
| 2016-09-30 | -51.23% |
| 2016-06-30 | -45.89% |
| 2016-03-31 | -37.32% |
| 2015-12-31 | -22.34% |
| 2015-09-30 | -45.95% |
| 2015-06-30 | -97.13% |
| 2014-12-31 | -53.58% |
